Sign inGet started

VRPX

Virpax Pharmaceuticals, Inc.CIK 1708331 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16

AI insights for VRPX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for VRPX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Field KatharynDirector1$0$02024-07-05
Dhaliwal JatinderDirector1$0$02024-07-05
Herman Gary LDirector1$0$02024-07-05
Mathias SheilaChief Scientific Officer1$0$02024-01-29
Ruskin BarbaraDirector2$0$02024-01-29
Dubin Michael FDirector4$0$02024-01-29
Sendrow JerroldDirector6$21.1K$02024-01-29
Floyd EricDirector5$6.1K$02024-01-29
Jambulingam ThaniDirector5$716$02024-01-29
Singh VanilaDirector4$0$02024-01-29
Shah VinayChief Financial Officer3$0$02024-01-29
Bruce Gerald WDirector3$0$02024-01-29
Mack Anthony P.Chief Executive Officer7$201.8K$02023-01-25
Gudin JeffreyChief Medical Officer4$0$02023-01-25
Chipman Christopher MichaelChief Financial Officer4$0$02023-01-25
JACOB GARY SDirector3$23.8K$02022-01-01

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Dhaliwal JatinderDirector A Award deriv2024-07-052024-07-092,500— $02,500SEC↗
Herman Gary LDirector A Award deriv2024-07-052024-07-092,500— $02,500SEC↗
Field KatharynDirector A Award deriv2024-07-052024-07-102,500— $02,500SEC↗
Ruskin BarbaraDirector A Award deriv2024-01-292024-01-3125,000— $025,000SEC↗
Floyd EricDirector A Award deriv2024-01-292024-01-3145,000— $045,000SEC↗
Bruce Gerald WChief Executive Officer A Award deriv2024-01-292024-01-31125,000— $0125,000SEC↗
Sendrow JerroldDirector A Award deriv2024-01-292024-01-3125,000— $025,000SEC↗
Dubin Michael FDirector A Award deriv2024-01-292024-01-3125,000— $025,000SEC↗
Mathias SheilaChief Scientific Officer A Award deriv2024-01-292024-01-31112,000— $0112,000SEC↗
Jambulingam ThaniDirector A Award deriv2024-01-292024-01-3125,000— $025,000SEC↗
Shah VinayChief Financial Officer A Award deriv2024-01-292024-01-31112,000— $0112,000SEC↗
Singh VanilaDirector A Award deriv2024-01-292024-01-3125,000— $025,000SEC↗
Shah VinayChief Financial Officer A Award deriv2023-06-202023-08-16100,000— $0100,000SEC↗
Shah VinayChief Financial Officer A Award deriv2023-06-202023-06-21100,000— $0100,000SEC↗
Bruce Gerald WDirector A Award deriv2023-04-242023-04-26100,000— $0100,000SEC↗
Ruskin BarbaraDirector A Award deriv2023-03-242023-03-2825,000— $025,000SEC↗
Chipman Christopher MichaelChief Financial Officer A Award deriv2023-01-252023-01-27112,000— $0112,000SEC↗
Mack Anthony P.Chief Executive Officer A Award deriv2023-01-252023-01-27125,000— $0125,000SEC↗
Gudin JeffreyChief Medical Officer A Award deriv2023-01-252023-01-2750,000— $050,000SEC↗
Mack Anthony P.Chief Executive Officer A Award deriv2023-01-252023-02-07125,000— $0125,000SEC↗
Jambulingam ThaniDirector A Award deriv2023-01-012023-01-0440,000— $040,000SEC↗
Singh VanilaDirector A Award deriv2023-01-012023-01-0415,000— $015,000SEC↗
Dubin Michael FDirector A Award deriv2023-01-012023-01-0420,000— $020,000SEC↗
Sendrow JerroldDirector A Award deriv2023-01-012023-01-0435,000— $035,000SEC↗
Floyd EricDirector A Award deriv2023-01-012023-01-0445,000— $045,000SEC↗
Sendrow JerroldDirector P Buy2022-05-242022-05-264,500$1.29 $5.8K9,006SEC↗
Floyd EricDirector P Buy2022-05-182022-05-204,479$1.36 $6.1K8,018SEC↗
Mack Anthony P.Chief Executive Officer P Buy2022-05-182022-05-2075,750$1.34 $101.5K252,562SEC↗
Bruce Gerald WDirector A Award deriv2022-04-252022-04-2760,000— $060,000SEC↗
Chipman Christopher MichaelChief Financial Officer A Award deriv2022-01-312022-02-02100,000— $0100,000SEC↗
Gudin JeffreyChief Medical Officer A Award deriv2022-01-312022-02-02100,000— $0100,000SEC↗
Mack Anthony P.Chief Executive Officer A Award deriv2022-01-312022-02-02150,000— $0150,000SEC↗
Chipman Christopher MichaelChief Financial Officer A Award deriv2022-01-312022-02-2560,676— $060,676SEC↗
Mack Anthony P.Chief Executive Officer A Award deriv2022-01-312022-02-2560,676— $060,676SEC↗
Gudin JeffreyChief Medical Officer A Award deriv2022-01-312022-02-2560,676— $060,676SEC↗
JACOB GARY SDirector A Award deriv2022-01-012022-01-0512,091— $012,091SEC↗
Floyd EricDirector A Award deriv2022-01-012022-01-0515,124— $015,124SEC↗
Dubin Michael FDirector A Award deriv2022-01-012022-01-0512,091— $012,091SEC↗
Singh VanilaDirector A Award deriv2022-01-012022-01-0512,091— $012,091SEC↗
Jambulingam ThaniDirector A Award deriv2022-01-012022-01-0514,113— $014,113SEC↗
Sendrow JerroldDirector A Award deriv2022-01-012022-01-0512,091— $012,091SEC↗
Sendrow JerroldDirector P Buy2021-11-222021-11-243,900$3.93 $15.3K4,506SEC↗
Mack Anthony P.Chief Executive Officer P Buy2021-11-182021-11-2225,125$3.99 $100.2K176,812SEC↗
Dubin Michael FDirector A Award deriv2021-07-262021-08-0520,225— $020,225SEC↗
JACOB GARY SDirector A Award deriv2021-04-072021-04-0913,183— $013,183SEC↗
Mack Anthony P.Chief Executive Officer A Award deriv2021-04-072021-04-0950,000— $050,000SEC↗
Chipman Christopher MichaelChief Financial Officer A Award deriv2021-04-072021-04-0925,000— $025,000SEC↗
Floyd EricDirector A Award deriv2021-04-072021-04-0911,216— $011,216SEC↗
Sendrow JerroldDirector A Award deriv2021-04-072021-04-0910,205— $010,205SEC↗
Jambulingam ThaniDirector A Award deriv2021-04-072021-04-0910,205— $010,205SEC↗
Singh VanilaDirector A Award deriv2021-04-072021-04-098,183— $08,183SEC↗
Gudin JeffreyChief Medical Officer A Award deriv2021-04-072021-04-0950,000— $050,000SEC↗
JACOB GARY SDirector P Buy2021-02-172021-02-193,500$6.79 $23.8K3,500SEC↗
Jambulingam ThaniDirector P Buy2021-02-172021-03-01100$7.16 $716100SEC↗